Paul Haluska is a seasoned leader in the pharmaceutical industry with extensive experience in oncology and clinical development. Currently serving as Head of Oncology, Global Medical & Evidence at Bayer since January 2025, Paul previously held the position of Vice President, Head of Solid Tumors at Karyopharm Therapeutics Inc. from March 2024 to January 2025. Prior roles include Vice President, Head of Clinical Search and Collaborations at Bristol Myers Squibb and Vice President, Worldwide Medical Lead at Merck. Paul’s foundational experience includes a tenure as Physician at Mayo Clinic and an MD from Rutgers Robert Wood Johnson Medical School, complemented by a Ph.D. in Molecular Pharmacology from Rutgers University.
This person is not in any teams
This person is not in any offices